Business · 21/04/20111 min read

FDA Corrects Final Rule on Ovarian Adnexal Mass Assessment Score Test System Classification

The Food and Drug Administration (FDA) is correcting a final rule that incorrectly classified the ovarian adnexal mass assessment score test system into class II (special controls) and published it with an incorrect docket number, which was announced in the Federal Register on March 23, 2011.